Samson Dauda's peptide therapy claims, fact-checked

What does this video actually claim?

Bodybuilder Samson Dauda promotes Morph Wellness, a telehealth platform offering "customized prescription treatment plans" for weight management, peptide therapy, anti-aging, hormone therapy, sexual wellness, and hair restoration. He credits them with taking care of his health during contest prep.

The post's hashtags suggest the company provides semaglutide, testosterone replacement therapy (TRT), and various peptides. Dauda presents this as comprehensive health optimization through "board-certified physicians" delivering "research-based medicine."

This is classic influencer marketing disguised as a testimonial. Dauda doesn't specify which treatments he's using or provide any measurable health outcomes.

Do peptides actually work for performance enhancement?

Most peptides promoted in fitness circles lack solid human evidence for performance benefits. BPC-157, heavily marketed for injury recovery, has zero published human trials despite decades of rodent studies showing promise.

Growth hormone-releasing peptides like CJC-1295 and ipamorelin can increase IGF-1 levels by 20-30% according to small studies (Teichman et al., Growth Hormone Research, 2006). But higher IGF-1 doesn't automatically translate to better recovery or muscle growth in healthy adults.

TB-500, derived from thymosin beta-4, showed potential for wound healing in a 2017 pilot study (Crockford et al., Wound Repair and Regeneration), but the research involved diabetic foot ulcers, not athletic recovery. The FDA hasn't approved any of these peptides for human use outside specific medical conditions.

What about the legitimate treatments they offer?

Semaglutide is the real deal for weight loss. The STEP 1 trial (Wilding et al., NEJM, 2021) found 14.9% weight loss at 68 weeks with 2.4mg weekly injections, compared to 2.4% with placebo.

Testosterone replacement can be appropriate for men with clinically low testosterone (below 300 ng/dL) and symptoms like fatigue or low libido. However, bodybuilders often use supraphysiologic doses that shut down natural production.

The problem isn't that these treatments don't work. It's that telehealth platforms often prescribe them to people who don't need them, particularly young men seeking performance enhancement rather than treating medical conditions.

What's wrong with this marketing approach?

Dauda never discloses what he's actually taking or whether he's being paid to promote Morph Wellness. This violates FTC guidelines requiring clear disclosure of material connections between endorsers and advertisers.

More concerning is the implication that professional bodybuilders represent normal health optimization. Dauda competes at an elite level that often involves medically risky practices. His "health" during contest prep isn't comparable to typical wellness goals.

The phrase "research-based medicine" sounds scientific but means nothing without specifics. Which research? For what conditions? At what doses?

What should you actually know?

Telehealth peptide clinics operate in a regulatory gray area. Many peptides aren't FDA-approved for the conditions they're marketed for, and quality varies wildly between compounding pharmacies.

If you're considering hormone therapy or weight loss medications, start with your primary care doctor. They can order proper labs and determine if you have an actual medical indication rather than just wanting to optimize performance.

Legitimate treatment focuses on addressing deficiencies or medical conditions, not turning healthy people into enhanced versions of themselves. That's the difference between medicine and biohacking.